These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37228746)

  • 21. Filling the gap: Genetic risk assessment in hypercholesterolemia using LDL-C and LPA genetic scores.
    Schwaninger G; Forer L; Ebenbichler C; Dieplinger H; Kronenberg F; Zschocke J; Witsch-Baumgartner M
    Clin Genet; 2023 Sep; 104(3):334-343. PubMed ID: 37417318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common and Rare
    Hsu LA; Teng MS; Wu S; Chou HH; Ko YL
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Genetic Variants Associated with Familial Hypercholesterolemia on Low-Density Lipoprotein-Cholesterol Levels and Cardiovascular Outcomes in the Million Veteran Program.
    Sun YV; Damrauer SM; Hui Q; Assimes TL; Ho YL; Natarajan P; Klarin D; Huang J; Lynch J; DuVall SL; Pyarajan S; Honerlaw JP; Gaziano JM; Cho K; Rader DJ; O'Donnell CJ; Tsao PS; Wilson PWF
    Circ Genom Precis Med; 2018 Dec; 11(12):. PubMed ID: 31106297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol Exposure.
    Clarke SL; Tcheandjieu C; Hilliard AT; Lee KM; Lynch J; Chang KM; Miller D; Knowles JW; O'Donnell C; Tsao PS; Rader DJ; Wilson PW; Sun YV; Gaziano JM; Assimes TL;
    Circ Genom Precis Med; 2022 Apr; 15(2):e003501. PubMed ID: 35143253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-Wide Association Study Identifies a Functional
    León-Mimila P; Villamil-Ramírez H; Macías-Kauffer LR; Jacobo-Albavera L; López-Contreras BE; Posadas-Sánchez R; Posadas-Romero C; Romero-Hidalgo S; Morán-Ramos S; Domínguez-Pérez M; Olivares-Arevalo M; López-Montoya P; Nieto-Guerra R; Acuña-Alonzo V; Macín-Pérez G; Barquera-Lozano R; Del-Río-Navarro BE; González-González I; Campos-Pérez F; Gómez-Pérez F; Valdés VJ; Sampieri A; Reyes-García JG; Carrasco-Portugal MDC; Flores-Murrieta FJ; Aguilar-Salinas CA; Vargas-Alarcón G; Shih D; Meikle PJ; Calkin AC; Drew BG; Vaca L; Lusis AJ; Huertas-Vazquez A; Villarreal-Molina T; Canizales-Quinteros S
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2494-2508. PubMed ID: 34233476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
    Lotta LA; Sharp SJ; Burgess S; Perry JRB; Stewart ID; Willems SM; Luan J; Ardanaz E; Arriola L; Balkau B; Boeing H; Deloukas P; Forouhi NG; Franks PW; Grioni S; Kaaks R; Key TJ; Navarro C; Nilsson PM; Overvad K; Palli D; Panico S; Quirós JR; Riboli E; Rolandsson O; Sacerdote C; Salamanca EC; Slimani N; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; McCarthy MI; Barroso I; O'Rahilly S; Savage DB; Sattar N; Langenberg C; Scott RA; Wareham NJ
    JAMA; 2016 Oct; 316(13):1383-1391. PubMed ID: 27701660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
    Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
    J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
    Nagahara K; Nishibukuro T; Ogiwara Y; Ikegawa K; Tada H; Yamagishi M; Kawashiri MA; Ochi A; Toyoda J; Nakano Y; Adachi M; Mizuno K; Hasegawa Y; Dobashi K
    J Atheroscler Thromb; 2022 May; 29(5):667-677. PubMed ID: 34011801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor.
    Rimbert A; Dalila N; Wolters JC; Huijkman N; Smit M; Kloosterhuis N; Riemsma M; van der Veen Y; Singla A; van Dijk F; ; Frikke-Schmidt R; Burstein E; Tybjærg-Hansen A; van de Sluis B; Kuivenhoven JA
    Eur Heart J; 2020 Mar; 41(9):1040-1053. PubMed ID: 31630160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
    Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the possible existence of a liver LDL-ostat, and its malfunctioning in familial hypercholesterolemia.
    Teixeira da Costa LF
    Med Hypotheses; 2021 Feb; 147():110500. PubMed ID: 33515861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study.
    Smith ML; Bull CJ; Holmes MV; Davey Smith G; Sanderson E; Anderson EL; Bell JA
    EBioMedicine; 2023 Apr; 90():104503. PubMed ID: 36870196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol.
    Meng FH; Liu S; Xiao J; Zhou YX; Dong LW; Li YF; Zhang YQ; Li WH; Wang JQ; Wang Y; Song BL; Ma YT; Fu ZY; Luo J
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1219-1233. PubMed ID: 37165876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.
    Zhang Y; Dron JS; Bellows BK; Khera AV; Liu J; Balte PP; Oelsner EC; Amr SS; Lebo MS; Nagy A; Peloso GM; Natarajan P; Rotter JI; Willer C; Boerwinkle E; Ballantyne CM; Lutsey PL; Fornage M; Lloyd-Jones DM; Hou L; Psaty BM; Bis JC; Floyd JS; Vasan RS; Heard-Costa NL; Carson AP; Hall ME; Rich SS; Guo X; Kazi DS; de Ferranti SD; Moran AE
    JAMA Cardiol; 2024 Mar; 9(3):263-271. PubMed ID: 38294787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular BChE as a therapeutic target to ameliorate hypercholesterolemia through PRMT5 selective degradation to restore LDL receptor transcription.
    Wang D; Tan KS; Zeng W; Li S; Wang Y; Xu F; Tan W
    Life Sci; 2022 Mar; 293():120336. PubMed ID: 35065166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keep recycling going: New approaches to reduce LDL-C.
    Klein-Szanto AJP; Bassi DE
    Biochem Pharmacol; 2019 Jun; 164():336-341. PubMed ID: 30953636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
    Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
    Handelman SK; Puentes YM; Kuppa A; Chen Y; Du X; Feitosa MF; Palmer ND; Speliotes EK
    Hepatol Commun; 2022 Nov; 6(11):3120-3131. PubMed ID: 36098472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels in vivo.
    Schiele F; Park J; Redemann N; Luippold G; Nar H
    J Mol Biol; 2014 Feb; 426(4):843-52. PubMed ID: 24252255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and analysis of individuals who deviate from their genetically-predicted phenotype.
    Hawkes G; Yengo L; Vedantam S; Marouli E; Beaumont RN; ; Tyrrell J; Weedon MN; Hirschhorn J; Frayling TM; Wood AR
    PLoS Genet; 2023 Sep; 19(9):e1010934. PubMed ID: 37733769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.